Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

The Vital Conference: Breckenridge 2026

A round discussion table with a central microphone stands before windows overlooking Colorado mountains.

The Vital Conference: Breckenridge 2026 is Psychedelics Today’s five-day professional development event at Residence Inn, Breckenridge, Colorado: welcome Friday, November 6; full-day presentations, panels and conversation on research, facilitation, ethics and care November 7–8; optional Music for Expanded States workshop November 9–10. Speakers: Susan Anzalone (Colorado MS Center, ibogaine for MS), Hayley Mann and Kevin Thorbahn (DreamMind Labs, extended-state DMT), Court Wing (REMAP Therapeutics / Psychedelics and Pain Association), Rev. Merrill Ward, Azul DelGrasso, Kalyana Bliss and Emily Wisdom; hosts: Kyle Buller and Joe Moore, Psychedelics Today and Vital co-founders. Open to anyone working in or around the psychedelic field; presenter slots reserved for Vital alumni; conference early bird $175 (ends October 5), Conference + Music Workshop $400, Workshop only $250; details: https://psychedelicstoday.com/2026/07/20/vital-conference-breckenridge-2026/

Hosted with: Psychedelic Writers Guild